These CDC guidelines provide recommendations for using and interpreting the QuantiFERON-TB test in the detection of TB infection.
This slide set depicts how TB is spread and to how differentiate between latent TB infection and active TB disease. It also lists symptoms of TB and discusses testing and treatment.
This brochure provides parents with important information on tuberculosis infection in children. It is designed in a question and answer format with highlighted information for quick and easy readability. The information covered ranges from the definitions of tuberculosis (TB) infection and TB disease to diagnosis and treatment of TB infection. In addition, tips on treatment improving adherence are provided to ensure completion.
This is a form for patients and case managers/health departments to sign indicating that they understand and agree to Directly Observed Therapy for treatment of TB.
This is a checklist agreement between clients and health care providers for their active tuberculosis (TB) treatment plan.
The questionnaire is a survey instrument that can be used to determine which health-care staff are involved in managing TB patients at the primary care level in National TB Programs that follow the DOTS strategy, and to assess the time needed to perform the tasks related to TB care. It is intended as a survey instrument, not as a planning tool.
General information about Tuberculosis on Beth Israel Deaconess Medical Center's website.
This fact sheet discusses TB transmission, infection, disease, diagnosis through a skin test, and treatment.
The Southeastern National Tuberculosis Center in collaboration with the Lung Health Center at the University of Alabama at Birmingham developed this TB-specific cultural competency guide for El Salvador. The guide provides epidemiological information for both TB and HIV in the country, nicknames for TB, common misperceptions surrounding the etiology, disease transmission, and cures for TB and HIV as well as the stigma surrounding these diseases.
This tool estimates the risk of active tuberculosis for an individual with a tuberculin skin test reaction of 5+mm, based on his/her clinical profile. It is intended for adults tested with standard tuberculin (5 TU PPDS, or 2 TU RT-23).
